In:
Ophthalmic Research, S. Karger AG, Vol. 66, No. 1 ( 2023), p. 14-26
Kurzfassung:
Uveal melanoma (UM) is the most common primary intraocular tumor in adults. New diagnostic procedures and basic science discoveries continue to change our patient management paradigms. A recent meeting of the European Vision Institute (EVI) special interest focus group was held on “Outcome Measures of New Technologies in Uveal Melanoma,” addressing the latest advances in UM, starting with genetic developments, then moving on to imaging and treatment of the primary tumor, as well as to investigating the most recent developments in treating metastases, and eventually taking care of the patient’s well-being. This review highlights the meeting’s presentations in the context of the published literature.
Materialart:
Online-Ressource
ISSN:
0030-3747
,
1423-0259
Sprache:
Englisch
Verlag:
S. Karger AG
Publikationsdatum:
2023
ZDB Id:
1483177-6
